CreatorsPublishersAdvertisers

Ebola vaccine regimen generates strong immune response in children and adults in a clinical trial in Sierra Leone

MedicalXpress
 2021-09-14

Cover picture for the articleJohnson & Johnson's two-dose Ebola vaccine regimen is safe, well tolerated and produces a strong immune response in people over the age of one, according to two new papers published in The Lancet Infectious Diseases. The EBOVAC-Salone study provides important further evidence for the potential of the regimen using...

medicalxpress.com

Comments / 0

Comments / 0